Article | May 20, 2020

NovaPure® Stoppers - The Right Choice For Oncology Drugs

By L. Fang, M. Gehrmann, R. Singh, C. Zhao, P. McAndrew

image1

Vial containment systems with NovaPure® elastomer stoppers offer substantial performance benefits with their enhanced dimension control, reduced particle levels, inspection of every stopper, and use of FluroTec® film. This article presents research that demonstrates the performance of FluroTec film and illustrates why NovaPure stoppers should be the choice for sensitive drug products such as those for oncology.

VIEW THE ARTICLE!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development

Please tell us more about you so that we can customize our newsletters to your specific interests:

West Pharmaceutical Services, Inc.